Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -4477.08% is 38106% below its 5-year average of -11.72%, near the low end of its 5-year range (-4477.08%–0.00%).
206.85% below its 12-month average of -1459.05%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-4477.08%
NET PROFIT MARGIN AVG TTM
-1459.05%
NET PROFIT MARGIN AVG 3Y
-439.39%
NET PROFIT MARGIN AVG 5Y
-11.72%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-206.85%
CURRENT VS 3Y AVG
-918.94%
CURRENT VS 5Y AVG
-38106.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-1721853.85%
vs the sector median at left
Korro Bio, Inc.
Market Cap
$97.49M
Net Profit Margin
-4477.08%
TTM Avg
-1459.05%
3Y Avg
-439.39%
5Y Avg
-11.72%
Market Cap
$98.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$96.58M
Net Profit Margin
-1.41%
TTM Avg
0.88%
3Y Avg
1.31%
5Y Avg
1.31%
Market Cap
$94.81M
Net Profit Margin
-3585.62%
TTM Avg
-2039.39%
3Y Avg
-2803.76%
5Y Avg
-1916.79%
Market Cap
$101.22M
Net Profit Margin
6.49%
TTM Avg
-2.90%
3Y Avg
-6.49%
5Y Avg
0.99%
Market Cap
$102.92M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1167.97%
5Y Avg
-1200.09%
Market Cap
$104.18M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korro Bio, Inc. (KRRO) | $97.49M | -4477.08% | -1459.05% | -439.39% | -11.72% |
| PolyPid Ltd. (PYPD)vs › | $97.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $98.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | -1.41% | 0.88% | 1.31% | 1.31% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $94.81M | -3585.62% | -2039.39% | -2803.76% | -1916.79% |
| Conexeu Sciences Inc. (CNXU)vs › | $96.46M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $101.22M | 6.49% | -2.90% | -6.49% | 0.99% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.92M | 0.00% | 0.00% | -1167.97% | -1200.09% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.00M | 31.95% | 15.97% | 7.99% | 5.33% |
Operating Margin
-1366.4%
Net Profit Margin
-4477.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -3873.22% |
| 2025-09-30 | -1656.97% |
| 2025-06-30 | -1765.07% |
| 2025-03-31 | -917.14% |
| 2024-12-31 | -933.47% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | -187.49% |
| 2021-03-31 | -438.08% |
| 2020-12-31 | -102.83% |
| 2020-09-30 | -47.49% |
| 2020-06-30 | -70.69% |
| 2020-03-31 | -67.63% |
| 2019-12-31 | -116.65% |
| 2019-09-30 | -2.37% |
